Publications by John A. Engh
41 publications found
Original articles
The relationship between the brain-derived neurotrophic factor and neurocognitive response to physical exercise in individuals with schizophrenia
Psychoneuroendocrinology, 157, 106356
DOI 10.1016/j.psyneuen.2023.106356, PubMed 37562099
Alterations in inflammatory markers after a 12-week exercise program in individuals with schizophrenia-a randomized controlled trial
Front Psychiatry, 14, 1175171
DOI 10.3389/fpsyt.2023.1175171, PubMed 37265560
Elevated Systemic Levels of Markers Reflecting Intestinal Barrier Dysfunction and Inflammasome Activation Are Correlated in Severe Mental Illness
Schizophr Bull, 49 (3), 635-645
DOI 10.1093/schbul/sbac191, PubMed 36462169
High-intensity interval training may reduce depressive symptoms in individuals with schizophrenia, putatively through improved VO2max: A randomized controlled trial
Front Psychiatry, 13, 921689
DOI 10.3389/fpsyt.2022.921689, PubMed 36003983
Systemic Cell Adhesion Molecules in Severe Mental Illness: Potential Role of Intercellular CAM-1 in Linking Peripheral and Neuroinflammation
Biol Psychiatry, 93 (2), 187-196
DOI 10.1016/j.biopsych.2022.06.029, PubMed 36182530
Quality of clinical management of cardiometabolic risk factors in patients with severe mental illness in a specialist mental health care setting
Nord J Psychiatry, 76 (8), 602-609
DOI 10.1080/08039488.2022.2039288, PubMed 35200088
Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study
Schizophr Bull, 48 (1), 37-46
DOI 10.1093/schbul/sbab106, PubMed 34499169
Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation
Brain Behav Immun, 99, 299-306
DOI 10.1016/j.bbi.2021.10.017, PubMed 34758379
Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms
BMC Psychiatry, 21 (1), 527
DOI 10.1186/s12888-021-03522-6, PubMed 34702245
High-intensity interval training and active video gaming improve neurocognition in schizophrenia: a randomized controlled trial
Eur Arch Psychiatry Clin Neurosci, 271 (2), 339-353
DOI 10.1007/s00406-020-01200-4, PubMed 33156372
Effect of high-intensity interval training on cardiorespiratory fitness, physical activity and body composition in people with schizophrenia: a randomized controlled trial
BMC Psychiatry, 20 (1), 425
DOI 10.1186/s12888-020-02827-2, PubMed 32854688
The Association Between Cardiorespiratory Fitness and Cognition Appears Neither Related to Current Physical Activity Nor Mediated by Brain-Derived Neurotrophic Factor in a Sample of Outpatients With Schizophrenia
Front Psychiatry, 10, 785
DOI 10.3389/fpsyt.2019.00785, PubMed 31708824
Objectively Assessed Daily Steps-Not Light Intensity Physical Activity, Moderate-to-Vigorous Physical Activity and Sedentary Time-Is Associated With Cardiorespiratory Fitness in Patients With Schizophrenia
Front Psychiatry, 10, 82
DOI 10.3389/fpsyt.2019.00082, PubMed 30863327
Body language reading of emotion and outcome in schizophrenia
Cogn Neuropsychiatry, 24 (1), 54-64
DOI 10.1080/13546805.2019.1568234, PubMed 30654697
Cardio-respiratory fitness is associated with a verbal factor across cognitive domains in schizophrenia
Schizophr Res, 206, 157-162
DOI 10.1016/j.schres.2018.11.033, PubMed 30528313
Physical activity pattern and cardiorespiratory fitness in individuals with schizophrenia compared with a population-based sample
Schizophr Res, 201, 98-104
DOI 10.1016/j.schres.2018.05.038, PubMed 29861267
Category fluency in schizophrenia: opposing effects of negative and positive symptoms?
Cogn Neuropsychiatry, 23 (1), 28-42
DOI 10.1080/13546805.2017.1418306, PubMed 29279010
The association between cardio-respiratory fitness and cognition in schizophrenia
Schizophr Res, 193, 418-422
DOI 10.1016/j.schres.2017.07.015, PubMed 28709774
Effects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trial
Trials, 16, 557
DOI 10.1186/s13063-015-1094-2, PubMed 26646670
Predictors of medication adherence in patients with schizophrenia and bipolar disorder
Acta Psychiatr Scand, 127 (1), 23-33
DOI 10.1111/j.1600-0447.2012.01911.x, PubMed 22900964
Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level
J Clin Psychopharmacol, 30 (2), 169-75
DOI 10.1097/JCP.0b013e3181d2191e, PubMed 20520290
Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia
Psychol Med, 40 (8), 1337-47
DOI 10.1017/S0033291709991620, PubMed 19891810
Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group
Schizophr Bull, 37 (1), 73-83
DOI 10.1093/schbul/sbp034, PubMed 19443616
Delusions are associated with poor cognitive insight in schizophrenia
Schizophr Bull, 36 (4), 830-5
DOI 10.1093/schbul/sbn193, PubMed 19176474
Using the Wisconsin Card Sorting Test to assess learning potential in normal IQ schizophrenia: does it have potential?
Nord J Psychiatry, 63 (5), 405-11
DOI 10.1080/08039480902879941, PubMed 19365785
The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness
Acta Psychiatr Scand, 118 (4), 297-304
DOI 10.1111/j.1600-0447.2008.01244.x, PubMed 18759810
Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions
J Clin Psychopharmacol, 28 (2), 132-7
DOI 10.1097/JCP.0b013e318166c4f7, PubMed 18344722
Can learning potential in schizophrenia be assessed with the standard CVLT-II? An exploratory study
Scand J Psychol, 49 (2), 179-86
DOI 10.1111/j.1467-9450.2008.00627.x, PubMed 18352988
Measurement of insight in patients with bipolar disorder: are self-rated scales developed for patients with schizophrenia applicable?
J Nerv Ment Dis, 196 (4), 333-5
DOI 10.1097/NMD.0b013e31816a62b2, PubMed 18414129
Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction
Bipolar Disord, 10 (2), 245-55
DOI 10.1111/j.1399-5618.2007.00492.x, PubMed 18271903
Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study
Acta Psychiatr Scand, 117 (2), 133-8
DOI 10.1111/j.1600-0447.2007.01135.x, PubMed 18081921
Measuring cognitive insight in schizophrenia and bipolar disorder: a comparative study
BMC Psychiatry, 7, 71
DOI 10.1186/1471-244X-7-71, PubMed 18072961
The effect of gender on emotion perception in schizophrenia and bipolar disorder
Acta Psychiatr Scand, 116 (4), 263-70
DOI 10.1111/j.1600-0447.2007.00991.x, PubMed 17803756
The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study
J Clin Psychiatry, 68 (6), 917-23
DOI 10.4088/jcp.v68n0614, PubMed 17592917
Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population
J Clin Psychiatry, 67 (3), 425-33
DOI 10.4088/jcp.v67n0314, PubMed 16649830
Toward effective needle steering in brain tissue
Conf Proc IEEE Eng Med Biol Soc, 2006, 559-62
DOI 10.1109/IEMBS.2006.260167, PubMed 17946405
Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent
J Neurosurg, 92 (2 Suppl), 191-6
DOI 10.3171/spi.2000.92.2.0191, PubMed 10763690
Review articles
Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions
Front Psychiatry, 5, 137
DOI 10.3389/fpsyt.2014.00137, PubMed 25309466
Verbal learning contributes to cognitive insight in schizophrenia independently of affective and psychotic symptoms
Prog Neuropsychopharmacol Biol Psychiatry, 35 (4), 1059-63
DOI 10.1016/j.pnpbp.2011.02.021, PubMed 21392553
Other articles
Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study
Schizophr Res, 228, 190-192
DOI 10.1016/j.schres.2020.11.051, PubMed 33450603
Psychosis relapse, medication non-adherence, and cannabis
Lancet Psychiatry, 4 (8), 578-579
DOI 10.1016/S2215-0366(17)30254-7, PubMed 28705599